While there are conflicting studies on the ability of adipokines, particularly cystatin C, adiponectin, and visfatin, to cross the BBB from the systemic circulation in the form of different molecular weight complexes or be produced within the CNS by endogenous means, recent research has revealed their potential as valuable biomarkers for a range of CNS disorders. This evidence concerns the gene ADIPOQ and central nervous system disorder.